EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges

Francesco Branda iD, Chiara Romano, Grazia Pavia iD, Viola Bilotta, Chiara Locci, Ilenia Azzena, Ilaria Deplano iD, Noemi Pascale, Maria Perra, Marta Giovanetti iD, Alessandra Ciccozzi, Andrea De Vito iD und 9 weitere

Viruses · 01.05.2025 · 17 (5) · 664

DOI: 10.3390/v17050664 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 01.05.2025. Verfasst von Francesco Branda und 20 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy. Hauptthemen laut MEDLINE: Deltaretrovirus Infections, Deltaretrovirus. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 258 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human T-lymphotropic viruses (HTLVs) are deltaretroviruses infecting millions of individuals worldwide, with HTLV-1 and HTLV-2 being the most widespread and clinically relevant types. HTLV-1 is associated with severe diseases such as adult T-cell leukemia/lymphoma (ATL) and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), while HTLV-2 shows a lower pathogenic potential, with occasional links to neurological disorders. HTLV-3 and HTLV-4, identified in Central Africa, remain poorly characterized but are genetically close to their simian counterparts, indicating recent zoonotic transmission events. HTLVs replicate through a complex cycle involving cell-to-cell transmission and clonal expansion of infected lymphocytes. Viral persistence is mediated by regulatory and accessory proteins, notably Tax and HBZ in HTLV-1, which alter host cell signaling, immune responses, and genomic stability. Integration of proviral DNA into transcriptionally active regions of the host genome may contribute to oncogenesis and long-term viral latency. Differences in viral protein function and intracellular localization contribute to the distinct pathogenesis observed between HTLV-1 and HTLV-2. Geographically, HTLV-1 shows endemic clusters in southwestern Japan, sub-Saharan Africa, the Caribbean, South America, and parts of the Middle East and Oceania. HTLV-2 is concentrated among Indigenous populations in the Americas and people who inject drugs in Europe and North America. Transmission occurs primarily via breastfeeding, sexual contact, contaminated blood products, and, in some regions, zoonotic spillover. Diagnostic approaches include serological screening (ELISA, Western blot, LIA) and molecular assays (PCR, qPCR), with novel biosensor and AI-based methods under development. Despite advances in understanding viral biology, therapeutic options remain limited, and preventive strategies focus on transmission control. The long latency period, lack of effective treatments, and global neglect complicate public health responses, underscoring the need for increased awareness, research investment, and targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deltaretrovirus InfectionsDeltaretrovirusHumansHuman T-lymphotropic virus 1Human T-lymphotropic virus 2AnimalsHTLV-I Infections

Stichwörter der Autor:innen

HAM/TSPHTLVadult T-cell leukemia/lymphomadeltaretrovirusepidemiologygenetic characterizationgenomicsmolecular diagnostics

Autor:innen und Institutionen

  • Unit of Medical Statistics and Molecular Epidemiology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
  • Unit of Clinical Microbiology, Department of Health Sciences, "Magna Græcia" University of Catanzaro-"Renato Dulbecco" Teaching Hospital, 88100 Catanzaro, Italy.
  • Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy.
  • Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy.
  • Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy.
  • Department of Science and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.

ORCID-Profile: Francesco Branda, Grazia Pavia, Ilaria Deplano, Marta Giovanetti, Andrea De Vito, Nadia Marascio, Giordano Madeddu, Marco Casu, Daria Sanna, Giancarlo Ceccarelli, Massimo Ciccozzi, Fabio Scarpa

Zitieren

APA

Branda, F., Romano, C., Pavia, G., Bilotta, V., Locci, C., Azzena, I., Deplano, I., Pascale, N., Perra, M., Giovanetti, M., Ciccozzi, A., De Vito, A., Quirino, A., Marascio, N., Matera, G., Madeddu, G., Casu, M., Sanna, D., Ceccarelli, G., …, & Scarpa, F. (2025). Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. Viruses, 17(5), 664. https://doi.org/10.3390/v17050664

Vancouver

Branda F, Romano C, Pavia G, Bilotta V, Locci C, Azzena I, et al. Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. Viruses. 2025;17(5):664. doi:10.3390/v17050664

BibTeX
@article{Branda2025,
  author = {Branda, Francesco and Romano, Chiara and Pavia, Grazia and Bilotta, Viola and Locci, Chiara and Azzena, Ilenia and Deplano, Ilaria and Pascale, Noemi and Perra, Maria and Giovanetti, Marta and Ciccozzi, Alessandra and De Vito, Andrea and Quirino, Angela and Marascio, Nadia and Matera, Giovanni and Madeddu, Giordano and Casu, Marco and Sanna, Daria and Ceccarelli, Giancarlo and Ciccozzi, Massimo and Scarpa, Fabio},
  title = {Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges},
  journal = {Viruses},
  year = {2025},
  volume = {17},
  number = {5},
  pages = {664},
  doi = {10.3390/v17050664}
}
Kostenlos starten →